Sign in

CIK 0001676725

  • Large accelerated filer

IDEAYA Biosciences, Inc.

Sign in to watch
Ticker
IDYA
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
474268251
Phone
+1 650-443-6209
Business address
5000 SHORELINE CT, SUITE 300, SOUTH SAN FRANCISCO, CA, 94080
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$985,397
in 1 filing, $985K under 10b5-1 plans

Net −$985,397. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. Hata Yujiro S −$985K President and CEO sold 4% of stake
Date Insider Transaction Shares Price Value Owned after
2019-07-26 Hager Jeffrey SVP, Chief Technology Officer Exercise or conversion +5,197 $4.31 $22K 127,853
2019-07-26 Hager Jeffrey SVP, Chief Technology Officer Exercise or conversion · Stock Option (right to buy) −5,197 10,396
2019-07-10 Hager Jeffrey SVP, Chief Technology Officer Exercise or conversion +7,145 $4.31 $31K 122,656
2019-07-10 Hager Jeffrey SVP, Chief Technology Officer Exercise or conversion · Stock Option (right to buy) −7,145 33,275
2019-06-19 Hager Jeffrey SVP, Chief Technology Officer Exercise or conversion +8,628 $4.31 $37K 115,511
2019-06-19 Hager Jeffrey SVP, Chief Technology Officer Exercise or conversion · Stock Option (right to buy) −8,628 40,420

Page 1 of 1 · 6 trades